FATE THERAPEUTICS INC (FATE) ROA
- 2026-06-30: ROA -48.44%.
- 2026-03-31: ROA -45.59%.
- 2025-12-31: ROA -42.74%.
- 2025-09-30: ROA -45.42%.
Complete source-backed roa history.
- Available history
- 2012-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|
| 2026-06-30 | -48.44% |
|---|
| 2026-03-31 | -45.59% |
|---|
| 2025-12-31 | -42.74% |
|---|
| 2025-09-30 | -45.42% |
|---|
| 2025-06-30 | -46.15% |
|---|
| 2025-03-31 | -44.12% |
|---|
| 2024-12-31 | -42.27% |
|---|
| 2024-09-30 | -36.01% |
|---|
| 2024-06-30 | -33.23% |
|---|
| 2024-03-31 | -33.35% |
|---|
| 2023-12-31 | -31.79% |
|---|
| 2023-09-30 | -31.84% |
|---|
| 2023-06-30 | -36.18% |
|---|
| 2023-03-31 | -37.27% |
|---|
| 2022-12-31 | -39.93% |
|---|
| 2022-09-30 | -39.23% |
|---|
| 2022-06-30 | -31.44% |
|---|
| 2022-03-31 | -27.12% |
|---|
| 2021-12-31 | -23.02% |
|---|
| 2021-09-30 | -19.97% |
|---|
| 2021-06-30 | -20.87% |
|---|
| 2021-03-31 | -17.68% |
|---|
| 2020-12-31 | -27.86% |
|---|
| 2020-09-30 | -23.72% |
|---|
| 2020-06-30 | -17.82% |
|---|
| 2020-03-31 | -34.77% |
|---|
| 2019-12-31 | -32.47% |
|---|
| 2019-09-30 | -25.24% |
|---|
| 2019-06-30 | -38.05% |
|---|
| 2019-03-31 | -32.70% |
|---|
| 2018-12-31 | -31.26% |
|---|
| 2018-09-30 | -28.67% |
|---|
| 2018-06-30 | -68.51% |
|---|
| 2018-03-31 | -50.27% |
|---|
| 2017-12-31 | -40.79% |
|---|
| 2017-09-30 | -52.83% |
|---|
| 2017-06-30 | -49.29% |
|---|
| 2017-03-31 | -41.26% |
|---|
| 2016-12-31 | -35.21% |
|---|
| 2016-09-30 | -66.88% |
|---|
| 2016-06-30 | -63.27% |
|---|
| 2016-03-31 | -51.93% |
|---|
| 2015-12-31 | -44.13% |
|---|
| 2015-09-30 | -37.67% |
|---|
| 2015-06-30 | -34.13% |
|---|
| 2015-03-31 | -60.20% |
|---|
| 2014-12-31 | -50.57% |
|---|
| 2014-09-30 | -54.01% |
|---|
| 2014-06-30 | -57.08% |
|---|
| 2014-03-31 | -49.00% |
|---|
| 2013-12-31 | -37.59% |
|---|
| 2013-09-30 | -83.81% |
|---|
Annual ROA
| Date | ROA |
|---|
| 2025-12-31 | -42.74% |
|---|
| 2024-12-31 | -42.27% |
|---|
| 2023-12-31 | -31.79% |
|---|
| 2022-12-31 | -39.93% |
|---|
| 2021-12-31 | -23.02% |
|---|
| 2020-12-31 | -27.86% |
|---|
| 2019-12-31 | -32.47% |
|---|
| 2018-12-31 | -31.26% |
|---|
| 2017-12-31 | -40.79% |
|---|
| 2016-12-31 | -35.21% |
|---|
| 2015-12-31 | -44.13% |
|---|
| 2014-12-31 | -50.57% |
|---|
| 2013-12-31 | -37.59% |
|---|
| 2012-12-31 | -128.56% |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
|---|
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
|---|
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
|---|
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
|---|
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
|---|
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
|---|
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
|---|
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
|---|
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
|---|
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
|---|